230 related articles for article (PubMed ID: 23729692)
21. Hemorrhage after ischemic stroke - relation to age and previous hemorrhage in a nationwide cohort of 58,868 patients.
Åsberg S; Henriksson KM; Farahmand B; Terént A
Int J Stroke; 2013 Feb; 8(2):80-6. PubMed ID: 22168375
[TBL] [Abstract][Full Text] [Related]
22. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
23. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
24. Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.
Scott DP; Greenfield JR; Bramah V; Alford J; Bennett C; Markus R; Campbell LV
Intern Med J; 2010 Apr; 40(4):275-80. PubMed ID: 19383060
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
[TBL] [Abstract][Full Text] [Related]
26. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
[TBL] [Abstract][Full Text] [Related]
27. Recurrent stroke after cervical artery dissection.
Weimar C; Kraywinkel K; Hagemeister C; Haass A; Katsarava Z; Brunner F; Haverkamp C; Schmid E; Diener HC;
J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):869-73. PubMed ID: 20682719
[TBL] [Abstract][Full Text] [Related]
28. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Thijs V; Lemmens R; Fieuws S
Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
[TBL] [Abstract][Full Text] [Related]
29. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
30. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
31. [Update on antithrombotic secondary prevention of ischemic stroke].
Köhrmann M; Kleinschnitz C
Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
[TBL] [Abstract][Full Text] [Related]
32. The emergency department: first line of defense in preventing secondary stroke.
Ovbiagele B
Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
[TBL] [Abstract][Full Text] [Related]
33. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
[TBL] [Abstract][Full Text] [Related]
34. Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
J Stroke Cerebrovasc Dis; 2007; 16(4):180-4. PubMed ID: 17689415
[TBL] [Abstract][Full Text] [Related]
35. Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack.
Uehara T; Minematsu K; Ohara T; Kimura K; Okada Y; Hasegawa Y; Tanahashi N; Suzuki A; Takagi S; Nakagawara J; Arii K; Nagahiro S; Ogasawara K; Uchiyama S; Matsumoto M; Iihara K; Toyoda K;
Int J Stroke; 2017 Jan; 12(1):84-89. PubMed ID: 27649736
[TBL] [Abstract][Full Text] [Related]
36. Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.
Van Schaik SM; Van den Berg-Vos RM; Weinstein HC; Bosboom WM
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1378-82. PubMed ID: 25804570
[TBL] [Abstract][Full Text] [Related]
37. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
[TBL] [Abstract][Full Text] [Related]
38. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
[TBL] [Abstract][Full Text] [Related]
39. Non-persistence with antiplatelet therapy in elderly patients after a transient ischemic attack.
Wawruch M; Zatko D; Wimmer G; Luha J; Wimmerova S; Kukumberg P; Murin J; Hloska A; Tesar T; Shah R
Aging Clin Exp Res; 2017 Dec; 29(6):1121-1127. PubMed ID: 28284002
[TBL] [Abstract][Full Text] [Related]
40. Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.
Eriksson SE
Brain Behav; 2017 Jan; 7(1):e00603. PubMed ID: 28127521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
